Clinical benefit of platinum doublet combination therapy in older adults with advanced non-small cell lung cancer: A prospective multicenter study by the National Hospital Organization in Japan.
Mototsugu ShimokawaMasaki KanazuRyusei SaitoMasahide MoriAtsuhisa TamuraYoshio OkanoYuka FujitaTakeo EndoMitsuru MotegiShohei TakataToshiyuki KitaNoriaki SukohFumitaka MizukiMitsuhiro TakenoyamaShinji AtagiPublished in: Thoracic cancer (2023)
Platinum doublet combination therapy may be beneficial in older patients with NSCLC. Identification of risk factors will assist in the development of a personalized treatment strategy.